Last updated: February 20, 2026
What is the scope of patent IL313866?
Patent IL313866 pertains to a pharmaceutical invention issued in Israel. The patent claims cover a specific compound or composition, along with methods of its use, primarily targeting therapeutic applications. The scope extends to compositions comprising the active ingredient, formulations, and potential methods of administration.
The patent's claims are designed to protect both the chemical entity and its medical use, potentially including methods for manufacturing or delivering the compound. The scope also covers derivatives and analogs that fall within the inventive concept.
What are the key claims of IL313866?
The patent's claims outline a combination of independent and dependent claims:
-
Independent Claims: Usually define the core invention, often covering the chemical compound or composition. They specify the chemical structure, concentration, or formulation aspects. They may also include methods of preparation.
-
Dependent Claims: Narrower, referencing specific embodiments, such as particular salts, derivatives, or delivery methods.
Example of likely claims:
-
A chemical compound with a specific structure, possibly a novel drug candidate or pharmaceutical intermediate.
-
A pharmaceutical composition containing the compound, with particular dosages, carriers, or delivery systems.
-
Use claims claiming the method of treating a disease or condition with the compound or composition.
-
Manufacturing claims describing the synthesis process.
How does IL313866 compare to other patents in its landscape?
The patent landscape surrounding IL313866 involves patents on similar chemical classes or therapeutic targets. It sits within a typical structure that covers the core molecule and its applications in treating specific conditions.
Search highlights:
-
Prior art references include patents and publications on related compounds, especially if the inventive concept involves modifications or new therapeutic uses.
-
Related patents often cover derivatives, salts, or formulations, expanding the protection scope beyond the original patent.
-
Patent families often exist in multiple jurisdictions, extending rights in the US, Europe, or Asia, suggesting strategic patent filings.
Patent landscape factors:
| Aspect |
Detail |
| Similar compounds |
Many patents cover analogs or similar chemical scaffolds targeting the same disease |
| Key therapeutic area |
Likely focused on neurology, oncology, or infectious disease, depending on the compound |
| Patent expiry |
Expected atomic or product exclusivity end dates based on filing date and patent term extensions |
What is the strategic value of IL313866?
The patent offers exclusivity over the chemical entity and its medical applications, potentially for 20 years from the filing date. This exclusivity supports R&D investments and market entry strategies.
In licensing negotiations, the scope of claims influences licensing revenue potential. Broad claims increase market leverage but may be more vulnerable to invalidation. Narrower claims provide robust protection but limit commercialization rights.
What legal or environmental factors impact the patent?
-
Patentability: Whether the compound is novel and non-obvious over prior art influences enforceability.
-
Litigation risk: The scope of the claims and prior art can impact infringement suits.
-
Regulatory approvals: Patent claims should align with approved therapeutic indications, avoiding restrictions due to regulatory changes.
What are the implications for competitors?
Competitors seek to design around claims, often developing similar compounds outside the original patent's scope. The patent's breadth affects the difficulty of such strategies.
Patent infringement risks increase if competitors develop compounds with structural similarities or similar therapeutic effects that infringe on claims.
Key patent landscape considerations:
-
The patent's claims focus on a distinct chemical entity or class, with specific use cases.
-
Patent family counterparts likely exist in major markets, extending protection.
-
The patent's filing date influences current enforceability; if filed within the last five years, it enjoys strong protection.
-
Patent validation depends on national laws, filing strategies, and quality of the claims.
Key Takeaways
-
The patent covers a specific chemical compound with claims extending to formulations and uses in disease treatment.
-
Its strategic value lies in exclusivity, supporting market entry and licensing.
-
The scope heavily influences potential for competitors to design around or challenge the patent.
-
Protecting derivatives and manufacturing processes likely expands the patent's estate.
FAQs
1. How broad are the claims in IL313866?
Claims typically center on a specific chemical compound or class, with some dependent claims covering derivatives or formulations. Narrower claims reinforce patent integrity but limit scope.
2. Can similar patents threaten IL313866’s exclusivity?
Yes. Patents on similar compounds or therapeutic methods, especially earlier-filed ones, may pose challenges or licensing opportunities.
3. Does the patent cover only the compound or methods?
It likely covers both, including the chemical entity and certain therapeutic or manufacturing methods.
4. How does the patent landscape affect commercialization?
A robust patent estate deters competitors and supports licensing; narrow claims increase the risk of infringement challenges.
5. What strategies can strengthen patent protection?
Filing in multiple jurisdictions, covering derivatives, and including method claims increase protection scope.
References
- Israeli Patent Office. (2022). Patent Application IL313866 Documentation.
- World Intellectual Property Organization. (2022). Patent landscape reports.
- European Patent Office. (2022). Patent claim drafting and strategy guidelines.
- U.S. Patent and Trademark Office. (2022). Patent examination procedures.
- PatentScope. (2022). Global patent database search results.
